iCAMPlogo TM horizontal final color
From The Gerontological Society of America’s 
National Adult Vaccination Program
ICAMP Academy is a 1⁄2-day multidisciplinary program for healthcare professionals who are committed to increasing adult vaccination rates, improving their patients’ health and improving quality metrics in their organization. ICAMP action planning aligns with the National Vaccine Advisory Committee (NVAC) Standards for Adult Immunization Practice and highlights the role of the immunization neighborhood.

2018 Trainings

Dallas, TX

 March 21

Gaylord Texan Resort Hotel
and Convention Center

Held in conjunction with AMDA/
PALTC annual meeting

Registration link 
for Dallas

Boston, MA November 13 Held in conjunction with GSA 
annual meeting

Registration link
for Boston

(Coming soon!)


Program objectives

  • Learn the skills needed to champion practice change
  • Create an action plan to mobilize your organization to improve adult immunization rates
  • Collaborate with multidisciplinary health care professionals
  • Establish your measurement parameters

Registration fees

  • The registration fee (a $175 value) is $39. Scholarships are available by contacting This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Registration includes program materials, live program and action planning, snack, and ongoing dialogue with 2016 and 2017 champions.

Attendee requirements

  • Participation in a pre-program webinar
  • Respond to 3 surveys over 12 months on adult immunization rate changes.

What 2016 ICAMP program participants are saying

  • “This training session provided me with excellent tools and resources to implement the much needed change in my practice/organization.”
  • "The ICAMP program and GSA were very helpful and informative. I would recommend [ICAMP] to anyone concerned with vaccines.”
  • “The multidisciplinary training broadened by my ideas about which process measures are needed to drive change.”


ICAMP is developed by The Gerontological Society of America and supported in part by Pfizer, Merck, and Sanofi Pasteur. 

Send your inquiries to This email address is being protected from spambots. You need JavaScript enabled to view it..